|
Volumn 2, Issue 9, 2014, Pages 846-856
|
In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates
a a a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
NIVOLUMAB;
PROGRAMMED DEATH 1 RECEPTOR;
ANIMAL;
ANTIGEN PRESENTING CELL;
BIOSYNTHESIS;
FEMALE;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
LYMPHOCYTE ACTIVATION;
MACACA FASCICULARIS;
MALE;
MOUSE;
NEOPLASMS;
TOXICITY TESTING;
TRANSGENIC MOUSE;
TUMOR ASSOCIATED LEUKOCYTE;
TUMOR CELL LINE;
TUMOR MICROENVIRONMENT;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGEN-PRESENTING CELLS;
CELL LINE, TUMOR;
FEMALE;
HUMANS;
IMMUNOTHERAPY;
LYMPHOCYTE ACTIVATION;
LYMPHOCYTES, TUMOR-INFILTRATING;
MACACA FASCICULARIS;
MALE;
MICE;
MICE, TRANSGENIC;
NEOPLASMS;
PROGRAMMED CELL DEATH 1 RECEPTOR;
TOXICITY TESTS;
TUMOR MICROENVIRONMENT;
|
EID: 84920031180
PISSN: None
EISSN: 23266074
Source Type: Journal
DOI: 10.1158/2326-6066.CIR-14-0040 Document Type: Article |
Times cited : (506)
|
References (0)
|